These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30737965)

  • 41. Coronary Access After Repeated Transcatheter Aortic Valve Implantation: A Glimpse Into the Future.
    Buzzatti N; Romano V; De Backer O; Soendergaard L; Rosseel L; Maurovich-Horvat P; Karady J; Merkely B; Ruggeri S; Prendergast B; De Bonis M; Colombo A; Montorfano M; Latib A
    JACC Cardiovasc Imaging; 2020 Feb; 13(2 Pt 1):508-515. PubMed ID: 31422142
    [No Abstract]   [Full Text] [Related]  

  • 42. Coronary Access After Transcatheter Aortic Valve Replacement in Patients With Bicuspid Aortic Valve: Lights and Shades.
    Tarantini G; Fabris T; Cardaioli F; Nai Fovino L
    JACC Cardiovasc Interv; 2019 Jun; 12(12):1190-1191. PubMed ID: 31153840
    [No Abstract]   [Full Text] [Related]  

  • 43. MitraClip and Transcatheter Aortic Valve Replacement in a Patient With Recurrent Heart Failure.
    Gandhi S; Natarajan MK; Chu V; Dokainish H; Mehta S; Velianou JL
    Circ Cardiovasc Interv; 2017 Sep; 10(9):. PubMed ID: 28893771
    [No Abstract]   [Full Text] [Related]  

  • 44. Emergency valve-in-valve transcatheter aortic valve replacement in a patient with degenerated bioprosthetic aortic stenosis and cardiogenic shock on veno-arterial extracorporeal membrane oxygenation.
    Summers MR; Mick S; Kapadia SR; Krishnaswamy A
    Catheter Cardiovasc Interv; 2018 Sep; 92(3):592-596. PubMed ID: 28296034
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A paradigm shift from surgical to transcutaneous aortic valve replacement (PARTNER 3 and Evolut Low Risk trials).
    Taggart DP
    Cardiovasc Res; 2019 Sep; 115(11):e107-e108. PubMed ID: 31436831
    [No Abstract]   [Full Text] [Related]  

  • 46. Performance of the Evolut-R 34 mm versus Sapien-3 29 mm in Transcatheter aortic valve replacement patients with larger annuli: Early outcome results of Evolut-R 34 mm as compared with Sapien-3 29 mm in patients with Annuli ≥26 mm.
    Eitan A; Witt J; Stripling J; Haselbach T; Rieß FC; Schofer J
    Catheter Cardiovasc Interv; 2018 Dec; 92(7):1374-1379. PubMed ID: 29521464
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bioprosthetic Valve Fracture Improves the Hemodynamic Results of Valve-in-Valve Transcatheter Aortic Valve Replacement.
    Chhatriwalla AK; Allen KB; Saxon JT; Cohen DJ; Aggarwal S; Hart AJ; Baron SJ; Dvir D; Borkon AM
    Circ Cardiovasc Interv; 2017 Jul; 10(7):. PubMed ID: 28698291
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bioprosthetic aortic valve durability in the era of transcatheter aortic valve implantation.
    Salaun E; Clavel MA; Rodés-Cabau J; Pibarot P
    Heart; 2018 Aug; 104(16):1323-1332. PubMed ID: 29735584
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fracture of the delivery balloon shaft during balloon-expandable prosthesis alignment during implantation of an Edwards SAPIEN 3.
    Arai T; Hovasse T; Chevalier B
    Catheter Cardiovasc Interv; 2018 Apr; 91(5):997-999. PubMed ID: 27142180
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Standardized Definition of Structural Valve Degeneration for Surgical and Transcatheter Bioprosthetic Aortic Valves.
    Dvir D; Bourguignon T; Otto CM; Hahn RT; Rosenhek R; Webb JG; Treede H; Sarano ME; Feldman T; Wijeysundera HC; Topilsky Y; Aupart M; Reardon MJ; Mackensen GB; Szeto WY; Kornowski R; Gammie JS; Yoganathan AP; Arbel Y; Borger MA; Simonato M; Reisman M; Makkar RR; Abizaid A; McCabe JM; Dahle G; Aldea GS; Leipsic J; Pibarot P; Moat NE; Mack MJ; Kappetein AP; Leon MB;
    Circulation; 2018 Jan; 137(4):388-399. PubMed ID: 29358344
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transcatheter Aortic and Mitral Valve-in-Valve Implantation Using the Edwards Sapien 3 Heart Valve.
    Shivaraju A; Michel J; Frangieh AH; Ott I; Thilo C; Schunkert H; Kastrati A; Leon MB; Dvir D; Kodali S; Bapat V; Guerrero M; Kasel AM
    J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 29982230
    [No Abstract]   [Full Text] [Related]  

  • 52. Valve-in-valve-in-valve: Balloon expandable transcatheter heart valve in failing self-expandable transcatheter heart valve in deteriorated surgical bioprosthesis.
    Schaefer A; Deuschl F; Conradi L; Schäfer U
    Catheter Cardiovasc Interv; 2018 Dec; 92(7):E481-E485. PubMed ID: 30196560
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Selection of Valve Prostheses.
    Rosu C; Soltesz EG
    Semin Thorac Cardiovasc Surg; 2015; 27(2):152-8. PubMed ID: 26686441
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The bailout transseptal approach during valve‑in‑valve transcatheter aortic valve implantation with difficult crossing of the degenerated Mitroflow bioprosthetic valve.
    Hudziak D; Ochała A; Gocoł R; Kozłowski M; Wojakowski W
    Kardiol Pol; 2021 Apr; 79(4):473-474. PubMed ID: 33723975
    [No Abstract]   [Full Text] [Related]  

  • 55. Stented within a stentless aortic valve. A simple surgical solution for the replacement of a stentless aortic bioprosthesis.
    Panagiotou M; Kogerakis N; Crockett JR; Economidou S
    Interact Cardiovasc Thorac Surg; 2010 Jan; 10(1):7-8. PubMed ID: 19805504
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The beginning of a new era in the field of percutaneous valvular interventions (PARTNER 3 and Evolut Low Risk trials).
    Dudek D
    Cardiovasc Res; 2019 Sep; 115(11):e105-e106. PubMed ID: 31436829
    [No Abstract]   [Full Text] [Related]  

  • 57. TAVR vs SAVR: Rising Expectations and Changing Indications for Surgery in Response to PARTNER II.
    Spadaccio C; Nappi F; Sablayrolles JL; Sutherland FWH
    Semin Thorac Cardiovasc Surg; 2017 Spring; 29(1):8-11. PubMed ID: 28684004
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Computed Tomography-Based Indexed Aortic Annulus Size to Predict Prosthesis-Patient Mismatch.
    Head SJ; Reardon MJ; Deeb GM; Van Mieghem NM; Popma JJ; Gleason TG; Williams MR; Radhakrishnan S; Fremes S; Oh JK; Chang Y; Boulware MJ; Kappetein AP
    Circ Cardiovasc Interv; 2019 Apr; 12(4):e007396. PubMed ID: 30929507
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Simultaneous transapical transcatheter mitral and aortic valve replacement for native valve stenosis.
    Wachter K; Rustenbach CJ; Hill S; Nikolai P; Schäufele T; Franke UF; Baumbach H
    J Cardiovasc Surg (Torino); 2017 Oct; 58(5):796-799. PubMed ID: 27654283
    [No Abstract]   [Full Text] [Related]  

  • 60. Valve-in-Valve Procedures in Failing Biological Xenografts Using a Novel Balloon-Expandable Device: Experience in Aortic, Mitral, and Tricuspid Positions.
    Schaefer A; Conradi L; Seiffert M; Lubos E; Blankenberg S; Reichenspurner H; Schaefer U; Treede H
    Thorac Cardiovasc Surg; 2016 Aug; 64(5):366-73. PubMed ID: 26277078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.